Haldol decanoate injection in deltoid

The influence of renal impairment on the pharmacokinetics of haloperidol has not been evaluated. About one-third of a haloperidol dose is excreted in urine, mostly as metabolites. Less than 3% of administered haloperidol is eliminated unchanged in the urine. Haloperidol metabolites are not considered to make a significant contribution to its activity, although for the reduced metabolite of haloperidol, back-conversion to haloperidol cannot be fully ruled out. Even though impairment of renal function is not expected to affect haloperidol elimination to a clinically relevant extent, caution is advised in patients with renal impairment, and especially those with severe impairment, due to the long half-life of haloperidol and its reduced metabolite, and the possibility of accumulation (see section ).

The drug is well and rapidly absorbed with a high bioavailability when injected intramuscularly. The T max is 20 minutes in healthy individuals and minutes in patients with schizophrenia. The mean T 1/2 is hours. [1] The decanoate injectable formulation is for intramuscular administration only and is not intended to be used intravenously. The plasma concentrations of haloperidol decanoate reach a peak at about six days after the injection, falling thereafter, with an approximate half-life of three weeks. [51]

Haldol decanoate injection in deltoid

haldol decanoate injection in deltoid

Media:

haldol decanoate injection in deltoidhaldol decanoate injection in deltoidhaldol decanoate injection in deltoidhaldol decanoate injection in deltoidhaldol decanoate injection in deltoid

http://buy-steroids.org